164 related articles for article (PubMed ID: 27116710)
1. Combretastatin A-4 derived 5-(1-methyl-4-phenyl-imidazol-5-yl)indoles with superior cytotoxic and anti-vascular effects on chemoresistant cancer cells and tumors.
Mahal K; Biersack B; Schruefer S; Resch M; Ficner R; Schobert R; Mueller T
Eur J Med Chem; 2016 Aug; 118():9-20. PubMed ID: 27116710
[TBL] [Abstract][Full Text] [Related]
2. 4,5-Diaryl-3H-1,2-dithiole-3-thiones and related compounds as combretastatin A-4/oltipraz hybrids: Synthesis, molecular modelling and evaluation as antiproliferative agents and inhibitors of tubulin.
Wang Z; Qi H; Shen Q; Lu G; Li M; Bao K; Wu Y; Zhang W
Eur J Med Chem; 2016 Oct; 122():520-529. PubMed ID: 27428395
[TBL] [Abstract][Full Text] [Related]
3. Anticancer properties of indole derivatives as IsoCombretastatin A-4 analogues.
Pecnard S; Hamze A; Bignon J; Prost B; Deroussent A; Gallego-Yerga L; Peláez R; Paik JY; Diederich M; Alami M; Provot O
Eur J Med Chem; 2021 Nov; 223():113656. PubMed ID: 34171660
[TBL] [Abstract][Full Text] [Related]
4. Gold(I) biscarbene complexes derived from vascular-disrupting combretastatin A-4 address different targets and show antimetastatic potential.
Muenzner JK; Biersack B; Kalie H; Andronache IC; Kaps L; Schuppan D; Sasse F; Schobert R
ChemMedChem; 2014 Jun; 9(6):1195-204. PubMed ID: 24648184
[TBL] [Abstract][Full Text] [Related]
5. Imidazole Analogs of Vascular-Disrupting Combretastatin A-4 with Pleiotropic Efficacy against Resistant Colorectal Cancer Models.
Reipsch F; Biersack B; Lucas H; Schobert R; Mueller T
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884888
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of indole-2-carbohydrazides and thiazolidinyl-indole-2-carboxamides as potent tubulin polymerization inhibitors.
Kazan F; Yagci ZB; Bai R; Ozkirimli E; Hamel E; Ozkirimli S
Comput Biol Chem; 2019 Jun; 80():512-523. PubMed ID: 31185422
[TBL] [Abstract][Full Text] [Related]
7. Combretastatin A-4 Analogue: A Dual-Targeting and Tubulin Inhibitor Containing Antitumor Pt(IV) Moiety with a Unique Mode of Action.
Huang X; Huang R; Gou S; Wang Z; Liao Z; Wang H
Bioconjug Chem; 2016 Sep; 27(9):2132-48. PubMed ID: 27494235
[TBL] [Abstract][Full Text] [Related]
8. New indole-based chalconoids as tubulin-targeting antiproliferative agents.
Mirzaei H; Shokrzadeh M; Modanloo M; Ziar A; Riazi GH; Emami S
Bioorg Chem; 2017 Dec; 75():86-98. PubMed ID: 28922629
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors.
Wang YT; Qin YJ; Yang N; Zhang YL; Liu CH; Zhu HL
Eur J Med Chem; 2015 Jun; 99():125-37. PubMed ID: 26070164
[TBL] [Abstract][Full Text] [Related]
10. Effects of the tumor-vasculature-disrupting agent verubulin and two heteroaryl analogues on cancer cells, endothelial cells, and blood vessels.
Mahal K; Resch M; Ficner R; Schobert R; Biersack B; Mueller T
ChemMedChem; 2014 Apr; 9(4):847-54. PubMed ID: 24678059
[TBL] [Abstract][Full Text] [Related]
11. A novel bis-indole destabilizes microtubules and displays potent in vitro and in vivo antitumor activity in prostate cancer.
Ahn S; Hwang DJ; Barrett CM; Yang J; Duke CB; Miller DD; Dalton JT
Cancer Chemother Pharmacol; 2011 Feb; 67(2):293-304. PubMed ID: 20383708
[TBL] [Abstract][Full Text] [Related]
12. 4-(3-Halo/amino-4,5-dimethoxyphenyl)-5-aryloxazoles and -N-methylimidazoles that are cytotoxic against combretastatin A resistant tumor cells and vascular disrupting in a cisplatin resistant germ cell tumor model.
Schobert R; Biersack B; Dietrich A; Effenberger K; Knauer S; Mueller T
J Med Chem; 2010 Sep; 53(18):6595-602. PubMed ID: 20731355
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis and Molecular Docking Studies of Novel Indole-Pyrimidine Hybrids as Tubulin Polymerization Inhibitors.
Hu MJ; Zhang B; Yang HK; Liu Y; Chen YR; Ma TZ; Lu L; You WW; Zhao PL
Chem Biol Drug Des; 2015 Dec; 86(6):1491-500. PubMed ID: 26177395
[TBL] [Abstract][Full Text] [Related]
14. Substitution at the indole 3 position yields highly potent indolecombretastatins against human tumor cells.
Álvarez R; Gajate C; Puebla P; Mollinedo F; Medarde M; Peláez R
Eur J Med Chem; 2018 Oct; 158():167-183. PubMed ID: 30216850
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
[TBL] [Abstract][Full Text] [Related]
16. Thiazolidinone Constraint Combretastatin Analogs as Novel Antitubulin Agents: Design, Synthesis, Biological Evaluation and Docking Studies.
Sharma S; Gupta MK; Saxena AK; Bedi PM
Anticancer Agents Med Chem; 2017; 17(2):230-240. PubMed ID: 27141882
[TBL] [Abstract][Full Text] [Related]
17. New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors.
La Regina G; Bai R; Coluccia A; Naccarato V; Famiglini V; Nalli M; Masci D; Verrico A; Rovella P; Mazzoccoli C; Da Pozzo E; Cavallini C; Martini C; Vultaggio S; Dondio G; Varasi M; Mercurio C; Hamel E; Lavia P; Silvestri R
Eur J Med Chem; 2018 May; 152():283-297. PubMed ID: 29730191
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological studies of novel tubulin inhibitors.
Sun Y; Pandit B; Chettiar SN; Etter JP; Lewis A; Johnsamuel J; Li PK
Bioorg Med Chem Lett; 2013 Aug; 23(15):4465-8. PubMed ID: 23790539
[TBL] [Abstract][Full Text] [Related]
19. Tivantinib (ARQ 197) exhibits antitumor activity by directly interacting with tubulin and overcomes ABC transporter-mediated drug resistance.
Aoyama A; Katayama R; Oh-Hara T; Sato S; Okuno Y; Fujita N
Mol Cancer Ther; 2014 Dec; 13(12):2978-90. PubMed ID: 25313010
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and structure-activity relationships of pyrimido[4,5-b]indole-4-amines as microtubule depolymerizing agents that are effective against multidrug resistant cells.
Devambatla RKV; Li W; Zaware N; Choudhary S; Hamel E; Mooberry SL; Gangjee A
Bioorg Med Chem Lett; 2017 Aug; 27(15):3423-3430. PubMed ID: 28610978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
